Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas.

Abstract

ACP Journal Club16 January 2018Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureasNatalia Genere, MD, Victor M. Montori, MD, MScNatalia Genere, MDMayo Clinic, Rochester, Minnesota, USA (N.G., V.M.M.)Search for more papers by this author, Victor M. Montori, MD, MScMayo Clinic, Rochester, Minnesota, USA (N.G., V.M.M.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2018-168-2-008 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationCADTH Therapeutic Reviews. New drugs for type 2 diabetes: second-line therapy–science report. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; Sep 2017.Clinical Impact RatingsGIM/FP/GP: Cardiology: Endocrinology: References1 Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes. 2016;9:504-12. [PMID: 27553599] Google Scholar2 Huang ES, Laiteerapong N, Liu JY, et al. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174:251-8. [PMID: 24322595] Google Scholar Author, Article, and Disclosure InformationAffiliations: Mayo Clinic, Rochester, Minnesota, USA (N.G., V.M.M.)This article was published at Annals.org on 2 January 2018. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHypoglycemia in type 2 diabetes mellitus patients — cerebral, cognitive, psychosocial and clinical aspectsThe optimization of ultrasonic-microwave assisted synergistic extraction of Lotus plumule extract rich in flavonoids and its hypoglycemic activityCurrent data on the effectiveness of gliclazide and molecular mechanisms of action of the drugrs622342 in SLC22A1, CYP2C9*2 and CYP2C9*3 and Glycemic Response in Individuals with Type 2 Diabetes Mellitus Receiving Metformin/Sulfonylurea Combination Therapy: 6-Month Follow-Up StudyManagement of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to TreatmentPhysicochemical properties of polysaccharides separated from Camellia oleifera Abel seed cake and its hypoglycemic activity on streptozotocin-induced diabetic mice 16 January 2018Volume 168, Issue 2Page: JC8KeywordsDrugsHypoglycemiaHypoglycemicsInsulinInsulin-like growth factorsMortalityNetwork analysisSafetySafety studiesType 2 diabetes ePublished: 16 January 2018 Issue Published: 16 January 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...